Singh, D., Singh, B., Chawla, P., & Chawla, V. (2026). Oral Peptide Nano‐Formulations for Breast Cancer: An Enhancer‐Centric, Regulatory‐Ready Path to Clinical Translation. Wiley. https://doi.org/10.1002/psc.70091
Chicago Style (17th ed.) CitationSingh, Dilpreet, Bishal Singh, Pooja A Chawla, and Viney Chawla. Oral Peptide Nano‐Formulations for Breast Cancer: An Enhancer‐Centric, Regulatory‐Ready Path to Clinical Translation. Wiley, 2026. https://doi.org/10.1002/psc.70091.
MLA (9th ed.) CitationSingh, Dilpreet, et al. Oral Peptide Nano‐Formulations for Breast Cancer: An Enhancer‐Centric, Regulatory‐Ready Path to Clinical Translation. Wiley, 2026. https://doi.org/10.1002/psc.70091.
Warning: These citations may not always be 100% accurate.